期刊文献+

晚期卵巢癌患者新辅助化疗适应证及间歇性肿瘤细胞减灭术手术时机选择 被引量:2

分享 导出
摘要 卵巢癌是目前世界上恶性程度较高的肿瘤之一,病死率居妇科肿瘤之首。由于其起病部位隐匿,生物学行为易早期扩散,前期临床症状无特异性,并且缺乏早期有效的诊断监测手段,约70%患者在初诊时已属卵巢癌晚期,5年生存率在19%-32%之间。
出处 《中国实用妇科与产科杂志》 CSCD 北大核心 2018年第2期232-236,共5页 Chinese Journal of Practical Gynecology and Obstetrics
基金 科技部重大慢性非传染性疾病防控研究(2016YFC1303701)
关键词 晚期卵巢癌 新辅助化疗 肿瘤细胞减灭术 advanced ovarian cancer neoadjuvant chemotherapy dehulking surgery
作者简介 通讯作者:潘凌亚,电子信箱:panly@pumch.cn
  • 相关文献

参考文献3

二级参考文献33

  • 1Hegazy MA, Hegazi RA, Elshafei MA, et al. Neoadjuvant chemotherapy versus primary surgery in advanced ovarian carcinoma [J]. World Journal of Surgical Oncology, 2005, 3( 1 ) :57-64. 被引量:1
  • 2Bristow RE,Tomacurz RS, Armstrong DK, et al. Survival effect of maximal cytoreductive surgery for advanced ovarian cmvinoma during the platinum era: a meta-analysis [ J ]. Clin Oncol, 2002, 20(5) : 1248-1259. 被引量:1
  • 3Weinberg LE,Rodriguez G,Hurteau JA, etal The role of neoadjuvant chemotherapy in treating advanced epithelial ovarian cancer[J]. J Surg Oncol,2010,101 (4) :334-343. 被引量:1
  • 4Pectasides D,Farmakis D, Koumarianou A, et al. The role of neoadjuvant chemotherapy in the treatment of advanced ovarian cancer[ J]. Oncology, 2005,68( 1 ) :64-70. 被引量:1
  • 5Vergote I,De Wever I, Decloedt J, et al. Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian carcinoma[J]. Semin Oncol, 2000, 27(Suppl. 7) : 31-36. 被引量:1
  • 6Steed H,Oza AM, Murphy J, et al. A retrospective analysis of neoadjuvant platinum-based chemotherapy versus up-front surgery in advanced ovarian cancer [ J ]. Int J Gynecol Cancer, 2006, 16 ( Suppl 1 ) :47-53. 被引量:1
  • 7Qayyum A,Coakley FV, Westphalen AC, et al. Role of CT and MR imaging in predicting optimal cytoreduetion of newly diagnosed primary epithelial ovarian cancer [ J ]. Gyneeol Oncol, 2005, 96(2) :301-306. 被引量:1
  • 8Lee SJ,Kim BG,Lee JW, et al. Preliminary. results of neoadjuvant chemotherapy with paclitaxel and cisplatin in patients with advanced epithelial ovarian cancer who are inadequate for optimum primary surgery[ J ]. Obstet Gynecol Res, 2006, 32 ( 1 ) : 90-106. 被引量:1
  • 9De laco P, Musto A,Orazi L, et al. FDG-PET/CT in advanced ovarian cancer staging: Value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy [J]. Eur J Radiot, 2010 Aug 3: [ Epub ahead of print]. 被引量:1
  • 10Risum S, Hogdall C, Loft A, et al. Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography-a prospective study[J]. Gyneeol Oncol, 2008, 108(2) :265-270. 被引量:1

共引文献75

同被引文献29

引证文献2

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈